Crohn's disease Trials in Xiamen, China
Conditions / Crohn's disease / Xiamen, China
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06430801 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | RECRUITING | — |
| NCT03926130 | A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | COMPLETED | PHASE3 |
| NCT04232553 | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06430801 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | RECRUITING | — |
| NCT06063967 | A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03345849 | A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies | COMPLETED | PHASE3 |
| NCT03599622 | An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease | TERMINATED | PHASE2 |
| NCT03466411 | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03345823 | A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 | ACTIVE_NOT_RECRUITING | PHASE3 |